NCT01847443View on ClinicalTrials.gov

Comparison of Pharmacokinetic Profiles of Two Nicotine Gum Formulations

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Smoking Cessation
Interventions
DRUG

Nicotine (2 mg)

2 mg nicotine gum in two formulations

DRUG

Nicotine (4 mg)

4 mg nicotine gum in two formulations

Trial Locations (1)

BT9 6AD

Celerion - BELFAST, Belfast

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01847443 - Comparison of Pharmacokinetic Profiles of Two Nicotine Gum Formulations | Biotech Hunter | Biotech Hunter